Latest News Releases From The Newsroom
REV Group Beats Estimates; Bullish View On Immunocore
September 13th, 2023
REV Group, Inc. (NYSE: REVG) exceeded expectations in its third-quarter fiscal 2023 earnings report, posting adjusted earnings of $0.35 per share compared to the consensus EPS estimate of $0.23. The company also outperformed in terms of quarterly sal. Read more
Spirit Airlines Lowers Outlook; Alnylam Stock Halted Amid FDA Panel Review
September 13th, 2023
Shares of Spirit Airlines, Inc. (NYSE: SAVE) experienced a dip in pre-market trading as it revised downwardly its third-quarter 2023 outlook. The company now anticipates revenues between $1.245 billion and $1.255 billion, a notable decrease from its . Read more
Momentum Builds: Workhorse's IRS Determination; Edgio's Upbeat Q2 Results
September 13th, 2023
Shares of Workhorse Group Inc. (Nasdaq: WKHS) soared over 20% in after-hours trading following the company's announcement of IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit. This approval opens the door for Workhorse . Read more
InnovAge Posts Mixed Results; Lockheed Martin Bags $841.4M+ Contract Modification
September 12th, 2023
InnovAge Holding Corp. (Nasdaq: INNV), a healthcare company, posted a fourth-quarter fiscal 2023 loss of $(0.09) per share, falling short of the consensus estimate loss of $(0.03). Nevertheless, the company reported quarterly sales of $176.87 million. Read more
Breaking: Asset Sale Deal Ignites Avalo Therapeutics
September 12th, 2023
Shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) surged by more than 40% following the company's announcement of a purchase agreement with AUG Therapeutics, LLC (AUG), wherein it will sell its rights, assets, and interests related to the 800 Series . Read more
Sight Sciences Takes a Hit: Revenue Outlook Falls Short
September 11th, 2023
Shares of Sight Sciences, Inc. (Nasdaq: SGHT) took a sharp nosedive in after-hours trading, plummeting over 15%. This drastic drop followed the company's announcement that its third-quarter 2023 total revenue is expected to be in the range of $19.0 m. Read more
Earnings Reaction Rollercoaster: Oracle Tumbles, Casey's Surges
September 11th, 2023
Oracle Corporation (NYSE: ORCL), a global technology company, reported first-quarter fiscal 2024 earnings of $1.19 per share, surpassing the consensus EPS estimate of $1.15. However, the company's quarterly revenues of $12.45 billion fell slightly be. Read more
FTC Says TruthFinder, Instant Checkmate Deceived Users About Background Report Accuracy, Violated FCRA While Marketing Reports for Employee and Tenant Screening
September 11th, 2023
Under proposed order, companies will pay $5.8 million penalty, implement FCRA monitoring program Washington D.C. / CRWE PRESS RELEASE / September 11, 2023 - The Federal Trade Commission will require background report providers TruthFind. Read more
FuelCell Energy Posts Mixed Results; Bullish View On Kenvue
September 11th, 2023
FuelCell Energy, Inc. (Nasdaq: FCEL), a renewable energy company, reported a third-quarter fiscal 2023 loss of $(0.06) per share, better than the consensus estimate loss of $(0.08). The company's quarterly sales amounted to $25.51 million, slightly b. Read more
Momentum: Crinetics' Acromegaly Study Data and Tesla's Morgan Stanley Boost
September 11th, 2023
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has reported promising results from its Phase 3 PATHFNDR-1 study evaluating paltusotine, an oral once-daily investigational compound designed for acromegaly treatment. The study achieved its primary endp. Read more
Member Login